MESOCOLIC: Mesenteric excision surgery or conservative limited resection in Crohn's disease
Trial Overview
Acronym | MESOCOLIC trial |
---|---|
Number | NCT03769922 |
Protocol Link | https://pubmed.ncbi.nlm.nih.gov/32085793/ |
Public Trial Registry Link | clinicaltrials.gov NCT03769922 |
Published Results Link | Not yet |
Status | Open/recruiting |
Category | IBD |
Treatment Course | Surgery |
Trial Description
Traditionally, surgical resection for Crohn's disease differs from oncological principles and the mesentery is preserved. This study sought to examine whether resection of the mesentery en bloc in suitable patients reduces post-operative recurrence. The primary endpoint is surgical recurrence. Secondary endpoints include endoscopic and clinical recurrence. This is a multi-centre study between Ireland, USA and China. |
Chief Investigator
Calvin Coffey Professor |
Profile Link |
Lead Centre
Weiming Zhu Center for Inflammatory Bowel Diseases, Department of General Surgery, Jinling Hospital, Medical School of Nanjing University, Nanjing, Jiangsu, China NA China |
Website |
Collaboration and Funding
Funding Sponsors
1. None No funding currently. |
Additional Information
Full Research SummaryObjective: | This study seeks to determine if a complete mesocolic resection reduces recurrenc compared to a limited mesocolic resection. |
Aim: | To establish whether complete mesocolic resection reduces recurrence risk in Crohn's disease. |
Methods: | Patients will be invited to participate and informed consent obtained. After laparoscopy or laparotomy, the surgeon will determine whether a hemostatic division of the mesentery is technically possible.If it is, the envelope containing the randomization can be opened to find out what group the patient has been randomized to, and the operation proceeds as per the group allocation to either a mesenteric-based resection or conventional resection. |
Reason for International Trial: | To enable sufficient recruitment of adequate numbers of patients. The target is n=116 |